Bristol-Myers Squibb Co expressed disappointment on Thursday with the opposition of its top shareholder to a $74 billion takeover of Celgene Corp, and said it would press on with what would be the largest pharmaceutical acquisition of all time.
Read more at: Source
Post Top Ad
Thursday, February 28, 2019
Home
business
Reuters: Business News
Bristol-Myers shares up after top investor resists Celgene deal
Bristol-Myers shares up after top investor resists Celgene deal
Tags
# business
# Reuters: Business News
About Asaljeplak
Reuters: Business News
Labels:
business,
Reuters: Business News
Subscribe to:
Post Comments (Atom)
Post Top Ad
Author Details
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates which are professionally designed and perfectlly seo optimized to deliver best result for your blog.
No comments:
Post a Comment